{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:31:40Z","timestamp":1781850700724,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtct.2023.12.014","type":"journal-article","created":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T14:00:42Z","timestamp":1703426442000},"page":"320.e1-320.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients"],"prefix":"10.1016","volume":"30","author":[{"given":"Patricia","family":"Mumby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-3808","authenticated-orcid":false,"given":"William","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8265-9340","authenticated-orcid":false,"given":"Patrick","family":"Stiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.12.014_bib0001","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1200\/JCO.2007.10.7805","article-title":"Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer","volume":"26","author":"Miller","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.014_bib0002","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1188\/08.ONF.802-807","article-title":"Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms","volume":"35","author":"Myers","year":"2008","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.jtct.2023.12.014_bib0003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jtct.2023.12.014_bib0004","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bmt.1704465","article-title":"Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation","volume":"33","author":"Sherman","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.014_bib0005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bbmt.2014.03.010","article-title":"Risk factors for depression in patients undergoing hematopoietic cell transplantation","volume":"20","author":"Artherholt","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.014_bib0006","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/cncr.29149","article-title":"Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation","volume":"121","author":"El-Jawahri","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.12.014_bib0007","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/sj.bmt.1705347","article-title":"Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation","volume":"37","author":"Andorsky","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.014_bib0008","doi-asserted-by":"crossref","first-page":"15265","DOI":"10.1038\/s41598-020-71208-2","article-title":"Pre-transplant depression decreased overall survival of patients receiving allogeneic hematopoietic stem cell transplantation: a nationwide cohort study","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2023.12.014_bib0009","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/pon.1261","article-title":"Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation","volume":"17","author":"Grulke","year":"2008","journal-title":"Psychooncology"},{"key":"10.1016\/j.jtct.2023.12.014_bib0010","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1200\/JCO.2005.05.751","article-title":"Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation","volume":"23","author":"Prieto","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.12.014_bib0011","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.bmt.1705419","article-title":"Do negative or positive emotions differentially impact mortality after adult stem cell transplant?","volume":"38","author":"Hoodin","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.014_bib0012","first-page":"e1740","article-title":"Effect of treating depressive disorders on mortality of cancer patients","volume":"9","author":"Sherrill","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.jtct.2023.12.014_bib0013","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: a meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.jtct.2023.12.014_bib0014","doi-asserted-by":"crossref","unstructured":"Hurley CL, Mumby PB, Di Iorio S, Stiff P. Psychosocial predictors of autologous bone marrow transplant patients\u2019 functioning: indications for early intervention. 2004;10:Poster session II. Tandem BMT 2004 Meeting, Orlando, FL.","DOI":"10.1016\/j.bbmt.2003.12.071"},{"key":"10.1016\/j.jtct.2023.12.014_bib0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bmt.1703557","article-title":"Assessment of psychological distress in prospective bone marrow transplant patients","volume":"29","author":"Trask","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.014_bib0016","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1182\/blood-2011-04-348730","article-title":"Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS)","volume":"118","author":"Sun","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.12.014_bib0017","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/bmt.2017.190","article-title":"Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany","volume":"52","author":"Kuba","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.014_bib0018","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF03544671","article-title":"Pretransplant psychological assessment for stem cell treatment","volume":"44","author":"Thilges","year":"2018","journal-title":"J Health Serv Psychol"},{"key":"10.1016\/j.jtct.2023.12.014_bib0019","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1176\/appi.psychotherapy.1994.48.4.494","article-title":"Review of research in supportive psychotherapy: an update","volume":"48","author":"Conte","year":"1994","journal-title":"Am J Psychother"},{"key":"10.1016\/j.jtct.2023.12.014_bib0020","first-page":"306","article-title":"Comparison of brief group therapies for depressed cancer patients receiving radiation therapy","volume":"110","author":"Evans","year":"1995","journal-title":"Public Health Rep"},{"issue":"suppl","key":"10.1016\/j.jtct.2023.12.014_bib0021","first-page":"12","article-title":"Depression and the cancer patient","volume":"51","author":"Massie","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jtct.2023.12.014_bib0022","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/pon.3925","article-title":"Psychological interventions for distress in adults undergoing haematopoietic stem cell transplantation: a systematic review with meta-analysis","volume":"25","author":"Baliousis","year":"2016","journal-title":"Psychooncology"},{"key":"10.1016\/j.jtct.2023.12.014_bib0023","article-title":"Antidepressants for the treatment of depression in people with cancer","volume":"3","author":"Vita","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtct.2023.12.014_bib0024","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpsychires.2019.10.009","article-title":"Prevention of depression in patients with cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"120","author":"Zahid","year":"2020","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jtct.2023.12.014_bib0025","first-page":"83","article-title":"Sertraline effectiveness and safety in depressed oncological patients","volume":"16","author":"Torta","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2023.12.014_bib0026","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.psym.2019.01.005","article-title":"Psychiatric care in hematopoietic stem cell transplantation","volume":"60","author":"Nakamura","year":"2019","journal-title":"Psychosomatics"},{"issue":"suppl B","key":"10.1016\/j.jtct.2023.12.014_bib0027","first-page":"18","article-title":"Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression","volume":"51","author":"Reimherr","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jtct.2023.12.014_bib0028","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0924-9338(99)80714-7","article-title":"A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients","volume":"14","author":"Sechter","year":"1999","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jtct.2023.12.014_bib0029","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0278-5846(03)00038-1","article-title":"Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicenter, randomized study","volume":"27","author":"Baca","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jtct.2023.12.014_bib0030","unstructured":"Zoloft. Highlights of prescribing information. Pfizer Pharmaceuticals. Available at: https:\/\/labeling.pfizer.com\/showlabeling.aspx?id=517#:\u223c:text=A%20dosage %20of%2025%20mg,of%20200%20mg%20per%20day. Accessed November 30, 2003."},{"key":"10.1016\/j.jtct.2023.12.014_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2001.tb00188.x","article-title":"The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders","volume":"7","author":"Macqueen","year":"2001","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.jtct.2023.12.014_bib0032","doi-asserted-by":"crossref","first-page":"76396","DOI":"10.1155\/2007\/76396","article-title":"Pro-and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy","volume":"2007","author":"Sutcigil","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jtct.2023.12.014_bib0033","unstructured":"American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder [online]. Available at:http:\/\/www.psych.org\/\/cme\/apacme\/courses\/introduction.cfm?apacme=00040001. Accessed May 13, 2003."},{"key":"10.1016\/j.jtct.2023.12.014_bib0034","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004850-199510030-00001","article-title":"Sertraline 50 mg daily: the optimal dose in the treatment of depression","volume":"10","author":"Preskorn","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jtct.2023.12.014_bib0035","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.291.19.2335","article-title":"Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma","volume":"291","author":"Syrjala","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2023.12.014_bib0036","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1700672","article-title":"Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale","volume":"19","author":"McQuellon","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.014_bib0037","series-title":"Beck Depression Inventory: Manual","author":"Beck","year":"1996"},{"key":"10.1016\/j.jtct.2023.12.014_bib0038","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the Cox model with cumulative sums of Martingale-based residuals","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.jtct.2023.12.014_bib0039","first-page":"678","article-title":"Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial","volume":"139","author":"Lydiatt","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jtct.2023.12.014_bib0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1470-2045(07)70148-1","article-title":"Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial","volume":"8","author":"Stockler","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2023.12.014_bib0041","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s12185-017-2309-y","article-title":"Effect of sertraline on complications and survival after hematopoietic stem-cell transplantation, a double-blind, placebo-controlled clinical study","volume":"106","author":"Tavakoli-Ardakani","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.12.014_bib0042","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41409-020-0937-y","article-title":"Associations among depression, antidepressants, survival and quality of life in hematopoietic cell transplant recipients","volume":"55","author":"Barata","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.12.014_bib0043","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/hea0000741","article-title":"PROMIS\u00ae: Standardizing the patient voice in health psychology research and practice","volume":"38","author":"Yount","year":"2019","journal-title":"Health Psychol"},{"key":"10.1016\/j.jtct.2023.12.014_bib0044","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723017499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723017499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:13:08Z","timestamp":1763003588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723017499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2666636723017499"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.12.014","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}